Avoid common mistakes on your manuscript.
Dear Editor,
A 36-year-old woman (gravida 1, para 0) at 9 weeks of gestation presented with vaginal bleeding and a non-viable fetus. Medical abortion was performed. Histologic examination showed normal product of gestation. However, vaginal bleeding persisted. During dilatation and curettage, a 1 cm plaque-like lesion at the posterior cervical lip was found. The biopsy showed an atypical mononuclear cellular infiltrate intermixed with eosinophil precursors (Fig. 1a). These neoplastic cells were medium sized, with a high nuclear/cytoplasmic ratio and fine chromatin pattern, consistent morphologically with blasts. Immunohistochemical staining showed that the blast cells were positive for CD45 (leucocyte common antigen) (Fig. 1b) and the myeloid marker myeloperoxidase (Fig. 1c), but were negative for CD34 and CD117. The overall features were consistent with myeloid sarcoma. The blood count, bone marrow aspirate, and karyotype were normal. A positron emission tomography–computed tomography (PET–CT) showed a 3.3 × 1.7 cm lesion at the uterine cervix, with standard uptake value maximum (SUVmax) of 7.4 (Fig. 1d). Another hypermetabolic focus (SUVmax 3.0) was noted at the left pelvic cavity, compatible with disease involvement. She was treated with a standard induction regimen for acute myeloid leukemia (AML) (cytarabine: 7 days; daunorubicin: 3 days). After 3 weeks, a reassessment PET–CT showed reduction of the cervical lesion to 2.5 × 1.3 cm with an SUVmax of 3.2 (Fig. 1e), consistent with partial response. She was treated with six further cycles of consolidation chemotherapy (etoposide: 5 days; daunorubicin: 2 days for two cycles; high dose cytarabine for four cycles). A reassessment PET–CT then showed complete response. The patient has remained in complete remission 16 months after diagnosis.
Myeloid sarcoma is rare, characterized by the myeloblasts presenting as tumor masses at extramedullary sites [1]. It may occur de novo, concurrently with AML or as blastic transformation of myelodysplastic syndrome or myeloproliferative neoplasm [2]. Frequent sites include: the skin, lymph nodes, mediastinum, gastrointestinal tract, bones, and testis [1, 2]. Myeloid sarcoma in the gynecological tract is very unusual, ovary and uterine cervix being involved in equal frequencies [3]. Around two-third of the cases had an antecedent myeloid neoplasms or concurrent AML [3–5]. Cervical myeloid sarcoma almost invariably presented as a mass lesion showing extensive tissue infiltration, manifesting as abdominal pain and vaginal bleeding [3–5].
Our case was special in several aspects. The disease was de novo. Interestingly, it presented as a missed abortion, an association not hitherto reported. Although examination showed a small plague, PET–CT revealed more extensive involvement, suggesting that the myeloid sarcoma might be causally related to abortion. PET–CT also showed involvement outside the uterus, so that it was instrumental in delineating the disease extent. As cervical carcinoma is far more common, and clinical presentation is similar, careful histopathologic evaluation, and awareness of the possibility of myeloid malignancies are required for the diagnosis of myeloid sarcoma.
References
Pileri SA, Orazi A, Falini B (2008) Myeloid Sarcoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thile J, Vardiman JW (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 140–141
Campidelli C, Agostini C, Stitson R, Pileri SA (2009) Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol 132:426–437
Garcia MG, Deavers MT, Knoblock RJ et al (2006) Myeloid sarcoma involving the gynaecological tract: a report of 11 cases and review of the literature. Am J Clin Pathol 125:783–790
Pathak B, Buchim I, Brisson ML et al (2005) Granulocytic sarcoma presenting as tumors of the cervix. Gynecol Oncol 98:493–497
Lee JW, Kim YT, Min YH et al (2004) Granulocytic sarcoma of the uterine cervix. In J Gynecol Cancer 14:553–557
Conflict of interest
All authors have no conflict of interest to declare.
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Gill, H., Loong, F., Mak, V. et al. Myeloid sarcoma of the uterine cervix presenting as missed abortion. Arch Gynecol Obstet 286, 1339–1341 (2012). https://doi.org/10.1007/s00404-012-2454-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2454-8